Cipher Pharmeuticals (CPH.TO)

Has avoided smaller pharmaceutical companies because he wears a hat as a generalist and couldn’t see the advantage he had of looking at a pharmaceutical name. Until a company gets to a specific scale where it is not taking as much drug specific risk, he would be very cautious about these names.

Has some zip to it. Long term it should do well.

He likes this and has a fairly large position, but his average cost is $7. The challenge going forward as it goes higher, is that they have a very high dependence on a single product. The challenge over time is to get diversification into their portfolio. He thinks this can definitely go higher, but some of the smaller names such as Nobilis (NHC-T), Patient Home Monitoring (PHM-X) and CRH Medical (CRH-T) would be better. If you had $3000, you could spread it over these 3 as there is still a lot of growth, but he wouldn’t have exposure to one individual name.

He would recommend the 3 Top Picks for this show over this stock, because they are just getting going. All 3 of them are related to the Bio/medical/Pharma world.

This looks like it could be breaking out. Everything is going well with its products and its relationship with Dr. Reddy’s (RDY-N). Good management.